Invitrogen Expands High-Throughput Assays With Molecular Probes Purchase
This article was originally published in The Gray Sheet
Invitrogen will enhance its high-throughput, drug discovery screening assays with Molecular Probes, Inc.'s fluorescent molecular labeling detection systems under a $325 mil. proposed acquisition
You may also be interested in...
Fisher Scientific will explore the viability of Perbio Science AB's medical device unit within a planned merger of the two companies, announced June 26
The president’s executive order aims to give smaller companies a leg up over foreign competitors, among other objectives.
No device-related warning letters were released by the US FDA the week of 26 January.